治療ガイドライン
子宮体がん治療ガイドライン2013年版（英語版）：（金原出版）
目次
Overview
CQ01 ：Which surgical techniques for hysterectomy are recommended for patients considered to be stage I
preoperatively?
CQ02 ：Which surgical hysterectomy techniques are recommended for patients considered to be stage II?
CQ03 ：What are the benefits of pelvic lymphadenectomy?
CQ04 ：What are the benefits of para-aortic lymphadenectomy (biopsy)?
CQ05 ：Is omentectomy necessary?
CQ06 ：Is ovarian preservation possible?
CQ07 ：What surgical technique is recommended for serous adenocarcinoma and clear-cell adenocarcinoma?
CQ08 ：Is an inguinal lymph node biopsy noted in the surgical staging guidelines necessary?
CQ09：What is a significance of preoperative diagnostic imaging?
CQ10：Is intraoperative frozen-section diagnosis useful to determine the optimal operative method?
CQ11：Should intraoperative frozen-section diagnosis be performed to detect lymph node metastases?
CQ12：Can lymphadenectomy be omitted if a sentinel node biopsy is performed?
CQ13：Should peritoneal cytology be conducted on the occasion of surgery?
CQ14：Can laparoscopic surgery become a standard surgical technique?
CQ15：How should patients who are confirmed to be endometrial cancer after hysterectomy be treated?
CQ16：What is the indication for the definitive radiation therapy?
Overview
CQ17 ：What are the indications and drugs recommended for postoperative chemotherapy?
CQ18 ：Is hormone therapy effective as a postoperative adjuvant therapy?
CQ19：What are the indications for postoperative whole-pelvis external-beam irradiation?
CQ20 ：What are the indications for postoperative irradiation of the para-aortic lymph node region and whole
abdomen?
Overview
CQ21 ：What intervals are recommended for post-treatment surveillance?
CQ22 ：Should pelvic examinations and vaginal vault smears be performed in post-treatment follow-up?
CQ23 ：Should serum tumor markers be measured in post-treatment follow-up?
CQ24 ：Should diagnostic imaging be performed in post-treatment follow-up?
CQ25 ：Is hormone replacement therapy recommended after treatment?
Overview
CQ26 ：What is the indication for surgery for clinical stages III and IV?
CQ27 ：Should neoadjuvant chemotherapy or preoperative radiation therapy be conducted for advanced cancer?
CQ28 ：What are the indications for surgery for recurrent cancer?
CQ29 ：Should chemotherapy be conducted for advanced cancer of imperfect resection and recurrent cancer?
CQ30 ：Should radiation therapy be conducted for recurrent and inoperable advanced cancer?
CQ31 ：Should hormone therapy be conducted for advanced and recurrent cancer?
Overview
CQ32 ：When patients with atypical endometrial hyperplasia desire for fertility preservation, is progesterone
therapy recommended?
CQ33 ：When patients with endometrioid adenocarcinoma (corresponding to G1) desire for fertility preservation,
is progesterone therapy recommended?
CQ34 ：What are suitable follow-up periods and examinations?
CQ35 ：What treatments are recommended for patients with recurrence after fertility preservation therapy?
CQ36 ：Is ovulation induction permissible in patients after fertility preservation therapy?
Overview
CQ37 ：What surgical techniques are recommended for uterine carcinosarcoma?
CQ38 ：What postoperative adjuvant therapy is recommended for uterine carcinosarcoma?
CQ39 ：What treatments are recommended for advanced and recurrent uterine carcinosarcoma?
CQ40 ：What surgical techniques and postoperative adjuvant therapy are recommended for uterine
leiomyosarcoma?
CQ41 ：What surgical techniques and postoperative adjuvant therapy are recommended for endometrial stromal
sarcoma (ESS)?
CQ42 ：What treatments are recommended for unresectable or recurrent ESS/leiomyosarcoma?
Overview
CQ43 ：What chemotherapy is recommended for an invasive mole, clinical invasive mole, or post-molar persistent
hCG?
CQ44 ：What chemotherapy is recommended for choriocarcinoma?
CQ45 ：What are the indications for surgery for choriocarcinoma?
CQ46 ：What are the indications for radiation therapy for choriocarcinoma?
CQ47 ：What treatments are recommended for cases with placental site trophoblastic disease (PSTT) or
epithelioid trophoblastic tumor (ETT)?
CQ48 ：How should patients with persistent low-positive hCG be treated?